Blcm stock price target
Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Bellicum Pharmaceuticals Inc have a median target of 18.00, with a high estimate of Their average twelve-month price target is $17.50, suggesting that the stock has a possible upside of 266.88%. The high price target for BLCM is $18.00 and the 1 Wall Street analysts have issued 1 year target prices for Bellicum Pharmaceuticals' stock. Their forecasts range from $17.00 to $18.00. On average, they expect Analyst price targets provided by TipRanks. Quick Links. Advanced Charting · After Hours Quote · Analyst Research
The stock had earned Overweight rating from Cantor Fitzgerald Markets when it published its report on January 31, 2018. That day the Cantor Fitzgerald set price target on the stock to $10. Wells Fargo was of a view that BLCM is Outperform in its latest report on March 08, 2017. Raymond James thinks that BLCM is worth Outperform rating.
Bellicum Pharmaceuticals - BLCM - Stock Price & News | The ... Real time Bellicum Pharmaceuticals (BLCM) stock price quote, stock graph, news & analysis. Real time Bellicum Pharmaceuticals (BLCM) stock price quote, stock graph, news & analysis. GT Biopharma Stock Forecast: up to 0.951 USD! - GTBP Stock ... GT Biopharma Stock Price Forecast, GTBP stock price prediction. Price target in 14 days: 0.219 USD. The best long-term & short-term GT Biopharma share price prognosis
2 brokers rate it as a 'Strong Buy'. Click to view NMQ:BLCM's StockReport. Size . Micro Cap. Style · Sucker Stock Price Target: ( below Price). 31st Dec 2020.
Bellicum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing cellular immunotherapies for various forms of cancer, including hematological cancers and solid tumors, as well as orphan inherited blood disorders.
View a financial market summary for BLCM including stock price quote, trading volume, volatility, options volume, statistics, and other important company data
View Price Target for BLCM Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Bellicum Pharmaceuticals, Inc. Common Stock (BLCM) Analyst ... Mar 27, 2020 · Find the latest analyst research for Bellicum Pharmaceuticals, Inc. Common Stock Based on analysts offering 12 month price targets for BLCM … BLCM - Bellicum Pharmaceuticals Summary, Stock ... - Benzinga
GT Biopharma Stock Price Forecast, GTBP stock price prediction. Price target in 14 days: 0.219 USD. The best long-term & short-term GT Biopharma share price prognosis
BLCM | Bellicum Pharmaceuticals Inc. Analyst Estimates ... BLCM updated stock price target summary. Dow Jones, a News Corp company. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. Bellicum Pharmaceuticals Price Target | BLCM View Price Target for BLCM Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Bellicum Pharmaceuticals, Inc. Common Stock (BLCM) Analyst ... Mar 27, 2020 · Find the latest analyst research for Bellicum Pharmaceuticals, Inc. Common Stock Based on analysts offering 12 month price targets for BLCM … BLCM - Bellicum Pharmaceuticals Summary, Stock ... - Benzinga
2 brokers rate it as a 'Strong Buy'. Click to view NMQ:BLCM's StockReport. Size . Micro Cap. Style · Sucker Stock Price Target: ( below Price). 31st Dec 2020. Wells Fargo analyst Jim Birchenough raised his price target for Bellicum Pharmaceuticals to $18 from $4 following the company's recent reverse stock split and 27 Feb 2020 The BLCM stock was last observed hovering at around $8.67 in the last It is also 90.21% off the consensus price target high of $90.00 offered Bellicum Pharmaceuticals (NASDAQ: BLCM) stock research, profile, news, on Bellicum Pharmaceuticals, Lowers Price Target to $17 Vick MeyerFri, 13 Mar